Green Thumb Industries (GTBIF) Change in Account Payables (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Change in Account Payables came in at -$4.6 million in Q1 2026, up 15.44% YoY from -$4.0 million in Q1 2025, and down 1095.85% on a QoQ basis from -$386000.0 in Q4 2025.
Green Thumb Industries (GTBIF) Change in Account Payables (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Change in Account Payables data on file, last reported at -$4.6 million in Q1 2026.
- Quarterly Change in Account Payables rose 15.44% year-over-year to -$4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $887000.0 (up 110.39% YoY) and the FY2025 annual result came in at $44000.0, down 83.82% from the prior year.
- Change in Account Payables fell to -$4.6 million in Q1 2026, from -$386000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $10.6 million in Q2 2023 to a low of -$9.6 million in Q3 2024.
- A 5-year average of $314294.1 and a median of $1.6 million in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 380.4% — and 2025, when it plunged 263.1%.
- Tracing GTBIF's Change in Account Payables over 5 years: stood at $3.8 million in 2022, then tumbled by 48.09% to $2.0 million in 2023, then jumped by 147.43% to $4.9 million in 2024, then sank by 107.85% to -$386000.0 in 2025, then sank by 1095.85% to -$4.6 million in 2026.
- The last three Change in Account Payables figures came in at -$4.6 million (Q1 2026), -$386000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn | -3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.66 Mn |
| Jun 30, 2026 | -3.66 Mn |
| Mar 31, 2026 | -4.62 Mn |
| Mar 31, 2026 | -4.62 Mn |
| Dec 31, 2025 | -386,000.00 |
| Dec 31, 2025 | -386,000.00 |
| Sep 30, 2025 | 2.13 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 3.76 Mn |
| Mar 31, 2025 | -5.46 Mn |
| Mar 31, 2025 | -5.46 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Mar 31, 2024 | 3.35 Mn |